Activity Overview
This online, on-demand virtual symposium brings together renowned experts in HER2+ metastatic breast cancer. In this educational program, these experts discuss evolving treatment options for HER2+ metastatic breast cancer, with a focus on frontline and maintenance settings. Topics include emerging combination induction therapies and sequencing strategies, with an emphasis on maintenance options and balancing disease control with quality of life.
This educational activity is an archive of the live symposium held on March 5, 2026.
Target Audience
This online educational activity is primarily directed toward medical oncologists, surgical oncologists, advanced practice providers, oncology nurses, oncology pharmacists, and other health care providers involved in the diagnosis and management of patients with breast cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Assess emerging clinical evidence supporting current and novel treatment strategies in the frontline setting for HER2+ MBC
- Develop individually tailored induction and maintenance regimens based on patient and disease characteristics
- Identify and manage adverse events associated with current frontline HER2-targeted therapies
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here